Discovery and structure-activity relationships of novel selective norepinephrine and dual serotonin/norepinephrine reuptake inhibitors

被引:30
|
作者
Boot, J
Cases, M
Clark, BP
Findlay, J
Gallagher, PT
Hayhurst, L
Man, T
Montalbetti, C
Rathmell, RE
Rudyk, H
Walter, MW
Whatton, M
Wood, V
机构
[1] Eli Lilly & Co, Lilly Res Ctr, Windlesham GU20 6PH, Surrey, England
[2] Evotec OAI, Abingdon OX14 4SD, Oxon, England
关键词
monoamine reuptake inhibitors; selective norepinephrine reuptake inhibitor; dual reuptake inhibitor; SAR; serotonin; norepinephrine;
D O I
10.1016/j.bmcl.2004.11.025
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Novel arylthiomethyl morpholines are potent selective norepinephrine reuptake inhibitors (NERIs) and dual serotonin/ norepinephrine reuptake inhibitors (SRI/NERIs). The target compounds were prepared using a stereochemically versatile synthesis featuring an aldol condensation as the key step. One enantiomer of the 2-methoxy-substituted analogue was found to be a potent and selective norepinephrine reuptake inhibitor, whereas the opposite enantiomer was a potent dual serotonin/norepinephrine reuptake inhibitor. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:699 / 703
页数:5
相关论文
共 50 条
  • [31] Structural Requirements for Modulating 4-Benzylpiperidine Carboxamides from Serotonin/Norepinephrine Reuptake Inhibitors to Triple Reuptake Inhibitors
    Paudel, Suresh
    Kim, Eunae
    Zhu, Anlin
    Acharya, Srijan
    Min, Xiao
    Cheon, Seung Hoon
    Kim, Kyeong-Man
    BIOMOLECULES & THERAPEUTICS, 2021, 29 (04) : 392 - 398
  • [32] Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors
    Lee, Ki-Ho
    Park, Chun-Eung
    Min, Kyung-Hyun
    Shin, Yong-Je
    Chung, Coo-Min
    Kim, Hui-Ho
    Yoon, Hae-Jeoung
    Won-Kim
    Ryu, Eun-Ju
    Shin, Yu-Jin
    Nam, Hyun-Sik
    Cho, Jeong-Woo
    Lee, Hee-Yoon
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (18) : 5567 - 5571
  • [33] Administration of serotonin and norepinephrine reuptake inhibitors tends to have less ocular surface damage in a chronic stress-induced rat model of depression than selective serotonin reuptake inhibitors
    Zhao, Han
    Yin, Yue
    Lin, Tong
    Wang, Wushuang
    Gong, Lan
    EXPERIMENTAL EYE RESEARCH, 2023, 231
  • [34] Serotonin norepinephrine re-uptake inhibitor ( SNRI)-, selective norepinephrine reuptake inhibitor (S-NRI)-, and exogenously administered norepinephrine-induced takotsubo syndrome: Analysis of published cases
    Y-Hassan, Shams
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 231 : 228 - 233
  • [35] Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors
    Fray, M. Jonathan
    Bish, Gerwyn
    Fish, Paul V.
    Stobie, Alan
    Wakenhut, Florian
    Whitlock, Gavin A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (16) : 4349 - 4353
  • [36] Selective serotonin reuptake inhibitor and serotonin-norepinephrine reuptake inhibitor associated cutaneous adverse drug reactions: A systematic review of case reports and case series
    Masuka, Josiah T.
    Mchunu, Nobuhle
    Mkhize, Zamambo
    Thandar, Yasmeen
    Mosam, Anisa
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 (01) : E13 - E20
  • [37] Exploration of substituted arylpiperazine-tetrazoles as promising dual norepinephrine and dopamine reuptake inhibitors
    Paudel, Suresh
    Acharya, Srijan
    Yoon, Goo
    Kim, Kyeong-Man
    Cheon, Seung Hoon
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (21) : 5546 - 5555
  • [38] Discovery and structure-activity relationships of a novel oxazolidinone class of bacterial type II topoisomerase inhibitors
    Lyons, Amanda
    Kirkham, James
    Blades, Kevin
    Orr, David
    Dauncey, Elizabeth
    Smith, Oliver
    Dick, Emma
    Walker, Rolf
    Matthews, Teresa
    Bunt, Adam
    Finlayson, Jonathan
    Morrison, Ian
    Savage, Victoria J.
    Moyo, Emmanuel
    Butler, Hayley S.
    Newman, Rebecca
    Ooi, Nicola
    Smith, Andrew
    Charrier, Cedric
    Ratcliffe, Andrew J.
    Stokes, Neil R.
    Best, Stuart
    Salisbury, Anne-Marie
    Craighead, Mark
    Cooper, Ian R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 65
  • [39] Antimicrobial activity of psychotropic drugs -: Selective serotonin reuptake inhibitors
    Munoz-Bellido, JL
    Munoz-Criado, S
    Garcìa-Rodrìguez, JA
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 14 (03) : 177 - 180
  • [40] The chronic use of serotonin norepinephrine reuptake inhibitors facilitates dyskinesia priming in early Parkinson's disease
    Marano, Massimo
    Pilotto, Andrea
    Padovani, Alessandro
    Gupta, Deepak
    Vivacqua, Giorgio
    Magliozzi, Alessandro
    Di Lazzaro, Vincenzo
    Carta, Manolo
    Meloni, Mario
    JOURNAL OF NEUROLOGY, 2024, 271 (07) : 3711 - 3720